Clerisy Corp.
Newly Launched FDA Market-Approved Medical Delivery Device Shown to Promote Appetite Control and Stress Management
Published in Medical Letter on the CDC and FDA, January 10th, 2010
Doctor-developed Nasal SoftStrips™ are a patented and FDA market-approved medical delivery device designed to provide consumers with a safe, effective and all-natural means to improve and manage their health and well being. Clerisy Corp. will initially offer two types of SoftStrips™, a peppermint blend to curb appetite and a lavender blend to promote relaxation and provide relief from stress and tension.
Vapors are released...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Research
Studies generate hundreds of leads in the fight against the H1N1 pandemic - Botulinum Toxin Therapy
Studies from University of British Columbia yield new data on botulinum toxin therapy - CSL Limited
Findings of Australian Trial of CSL's Pandemic H1N1 2009 'Swine' Flu Vaccine in Children Published in Journal of the American Medical Association JAMA - Depression
Report summarizes depression study findings from University of Hull - Fred Hutchinson Cancer Research Center
Aggressive Infection Control Program Protects Cancer Patients from Acquiring Clinic-Based H1N1 Influenza - GenSpera, Inc.
GenSpera Receives Approval to Commence G-202 Phase I Trial at the University of Wisconsin Carbone Cancer Center - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
